Source: Slovak Spectator

The Health Ministry approved the therapeutic use of Ivermectin for six months.

Ivermectin, a medication used to treat many types of parasite infestations, can now be used to treat coronavirus patients in hospitals and obtained from pharmacies with a prescription.

The Health Ministry approved the therapeutic use of this medication for six months. It will be used with other treatments, its spokesperson Zuzana Eliášová said, as reported by the TASR newswire.

The medication can be legally imported to Slovakia and given to patients. With such a step, the ministry fulfilled the request of the association of Slovak anaesthetists, the Denník N daily reported.






Related: HCQ and Ivermectin included in multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk COVID-19

Ivermectin for Covid-19: Database of all Ivermectin COVID-19 studies – 35 trials and growing

Use of Ivermectin as a potential chemoprophylaxis for COVID-19 in Egypt : A randomised clinical trial

IVERMECTIN IS INCLUDED IN COVID-19 TREATMENT AGAIN: Peru

La Pampa will begin to treat coronavirus patients with Ivermectin: Argentina

Malaysia to run trials for 2 drugs in Covid-19 treatment, including Ivermectin

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Stark madness to ban ivermectin

Buried in the note is the real reason for making ivermectin inaccessible – the fear that persons taking it ‘may elect not to be vaccinated as part of the national Covid-19 vaccination program’. This is outrageous. When someone is infected with Covid, it is too late to bother with vaccination. They need early treatment. To deny it to coerce them into accepting a vaccine, one of whose side-effects is death, is immoral.

Read More »

Australia’s TGA Bans GPs from Prescribing Ivermectin

Australia’s medicine and therapeutic regulatory, the Therapeutic Good Administration (TGA) recently took the gloves off with Ivermectin, the economical anti-parasitic drug associated with at least 63 completed clinical trials involving SARS-CoV-2, the virus behind COVID-19. Now TGA formally places a national prohibition on off-label prescribing of ivermectin to all general practitioners. A comparable move as to what TGA did with hydroxychloroquine in 2020. Clearly further evidence of tightening encroachment of the critically important doctor-patient treatment relationship allowing consent to medical treatment using off-label medications. Of course, this isn’t occurring in a vacuum—it’s part of an unfolding, integrated and what have the signs of a coordinated and orchestrated government action to stop any and all treatments other than those the government declares acceptable.

Read More »